Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Massimo Group Expands UTV Lineup with New Buck 450 and T-Boss 900L Crew Models 2025-10-13 20:30
YY Group Launches Bursary Award for Gig Workers Pursuing Higher Education 2025-10-13 20:00
Markel International appoints Tom Hillier as CUO and announces new international structure 2025-10-13 19:34
Daqo New Energy to Announce Unaudited Results for the Third Quarter of 2025 on October 27, 2025 2025-10-13 19:00
Bright Scholar Enters into Definitive Agreement for Going-Private Transaction 2025-10-13 18:30
Solidion Technology Unveils Advanced UPS Battery System Tailored for AI Data Centers 2025-10-13 18:00
Promoting Local Industry: 3M and PT Pipa Mas Putih Collaborate in Indonesia 2025-10-13 16:40
Promoting Local Industry: 3M and PT Pipa Mas Putih Collaborate in Indonesia 2025-10-13 16:23
AnnJi Showcases Clinical Breakthrough of AJ201 at WMS 2025 2025-10-13 16:03
HGS Opens a New Intelligent Experience Hub in Manila, Philippines 2025-10-13 15:10
LG SHOWCASES PUROTEC™ ANTIMICROBIAL MATERIAL AT K SHOW IN GERMANY 2025-10-13 15:08
Lundbeck's bexicaserin receives Breakthrough Therapy Designation in China for the treatment of seizures in severe rare epilepsies 2025-10-13 14:26
Visa cardholders worldwide to get early access to 2025 MAMA AWARDS tickets 2025-10-13 13:00
GC Biopharma Secures CMO Rights for Shingles Vaccine from Curevo Vaccine 2025-10-13 12:38
DXC Launches Assure Smart Apps to Accelerate AI-Driven Innovation in the Insurance Industry 2025-10-13 12:01
Agoda Data Shows 67% Rise in International Travel Interest to India During Diwali 2025 2025-10-13 09:05
CommScope and Nokia Announce Combined FTTH Solution 2025-10-13 09:00
Trip.com Group and Live Nation Asia Announce Strategic Partnership to Power Concert Travel 2025-10-13 09:00
Everest Medicines Announces NMPA Approval of IND Application for Tumor-Associated Antigen Cancer Vaccine EVM14 2025-10-13 08:47
Ascletis Selects a Best-In-Class Once-Monthly Subcutaneously Administered GLP-1R/GIPR Dual Peptide Agonist, ASC35, for Clinical Development 2025-10-13 08:10